Effect and tolerance of a low dose ovulation inhibitor (Orlest)
Koester, H.; Hertel, H.
Münchener Medizinische Wochenschrift 111(41): 2103-2109
1969
ISSN/ISBN: 0341-3098 PMID: 5395280 Document Number: 479424
Document emailed within 1 workday
Related Documents
Poiret, C.; Picavet, B. 1970: Clinical trials of a low-dose inhibitor of ovulation Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 1970(Suppl 4): 737-739Kayan, S.; Mitchell, C.L. 1972: Studies on tolerance development to morphine: effect of the dose-interval on the development of single dose tolerance Archives Internationales de Pharmacodynamie et de Therapie 199(2): 407-414
Kaiser, E. 1986: Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female Geburtshilfe und Frauenheilkunde 46(10): 738-742
Jain, J.; Dutton, C.; Nicosia, A.; Wajszczuk, C.; Bode, F.R.; Mishell, D.R. 2004: Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera Contraception 70(1): 11-18
Souka, A.R.; el Sokkary, H.; Kamel, M.; Hassan, M. 1986: The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation Contraception 33(4): 365-371
Shatrugna, V.; Raman, L.; Kailash, U.; Balakrishna, N.; Rao, K.V. 1999: Effect of dose and formulation on iron tolerance in pregnancy National Medical Journal of India 12(1): 18-20
Hui, K.S. 1976: The effect of thiazol-4-yimethoxyamine, a histidine decarboxylase inhibitor, on the development of morphine tolerance and physical dependance in mice Experientia 32(10): 1313-1315
Fagard, R.; Amery, A.; Lijnen, P.; Staessen, J. 1980: First dose effect of the oral angiotensin converting enzyme inhibitor captopril Archives Internationales de Pharmacodynamie et de Therapie Suppl: 178-187
Küçük, M.; Sezer, S.D.; Odabaşi, A.R.; Güner, Z.; Yuksel, H.; Serter, M. 2011: The effect of low-dose combined oral contraceptive containing 100 ug levonorgestrel on plasma plasminogen activator inhibitor-1 concentrations Clinical and Experimental Obstetrics and Gynecology 38(1): 54-56
Navratil, H.; Costa, P.; Louis, J.F.; Andro, M.C.; Saur, P. 1995: Effectiveness of and tolerance to intracavernous injection of moxisylyte in patients with erectile dysfunction: effect/dose relationship versus placebo Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(5): 690-696
Winsberg, B.; Matinsky, S.; Kupietz, S.; Richardson, E. 1987: Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: oral dose and plasma considerations Psychopharmacology Bulletin 23(1): 107-110
Schneider, W.H.; Schmid, R.; Spona, J. 1981: The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor Wiener Klinische Wochenschrift 93(19): 601-604
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Gerber, E. 1965: Practical experiences with ovulation inhibitors Influence of ovulation. Medicamentous stimulation and inhibition of ovulation. Report of the 3rd Bavarian-Austrian- Swiss Gynecological Convention, Luzerne, October, 1963 Bibl Gynaecol 32: 135-140
Goris, J. 1972: Experiences with a further developed sequence-type ovulation inhibitor (Kombiquens) in gynecologic or ambulatory care Die Medizinische Welt 23(1): 38-39
Kaiser, R. 1965: Practical experiences with inhibition of ovulation Influence of ovulation. Medicamentous stimulation and inhibition of ovulation. Report of the 3rd Bavarian-Austrian- Swiss Gynecological Convention, Luzerne, October, 1963 Bibl Gynaecol 32: 107-111
Hester, K.E.; Harper, M.J.K.; Duffy, D.M. 2010: Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception Human Reproduction 25(2): 360-367
Peeters, F.; Oeyen, R.; Van, R.y, M. 1965: Some therapeutic indications of ovulation inhibition by cyclic treatment with Anovlar Influence of ovulation. Medicamentous stimulation and inhibition of ovulation. Report of the 3rd Bavarian-Austrian- Swiss Gynecological Convention, Luzerne, October, 1963 Bibl Gynaecol 32: 141-147
Verho, M.; Dagrosa, E.E.; Usinger, P.; Grötsch, H.; Malerczyk, V.; Uchida, M.; Rangoonwala, R. 1985: Renal tolerance of ofloxacin, a new gyrase inhibitor Pharmatherapeutica 4(5): 306-313
Winter, J.C. 1971: Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component Journal of Pharmacology and Experimental Therapeutics 178(3): 625-630